PTP — Pentixapharm Holding AG Balance Sheet
0.000.00%
- €53.53m
- €48.91m
- €0.09m
Annual balance sheet for Pentixapharm Holding AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 23.2 | 4.62 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 6.94 | 0.22 |
| Total Other Current Assets | ||
| Total Current Assets | 31.3 | 5.99 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 0.269 | 0.036 |
| Net Intangible Assets | ||
| Long Term Investments | ||
| Other Long Term Assets | ||
| Total Assets | 68.3 | 41.9 |
| Accounts Payable | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 14 | 3.46 |
| Total Long Term Debt | ||
| Total Debt | ||
| Deferred Income Tax | ||
| Total Other Liabilities | ||
| Total Liabilities | 18 | 6.79 |
| Common Stock | ||
| Retained Earnings (Accumulated Deficit) | ||
| Treasury Stock | ||
| Total Equity | 50.3 | 35.1 |
| Total Liabilities & Shareholders' Equity | 68.3 | 41.9 |
| Total Common Shares Outstanding |